CytomX Therapeutics, Inc. (CTMX)
2.56
-0.02
(-0.78%)
USD |
NASDAQ |
Oct 06, 16:00
2.60
+0.04
(+1.56%)
After-Hours: 20:00
CytomX Therapeutics Price to Book Value : 1.847 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 1.847 |
| October 05, 2026 | 1.861 |
| October 02, 2026 | 1.847 |
| October 01, 2026 | 1.897 |
| September 30, 2026 | 1.962 |
| September 29, 2026 | 1.984 |
| September 28, 2026 | 1.940 |
| September 25, 2026 | 1.948 |
| September 24, 2026 | 1.984 |
| September 23, 2026 | 2.005 |
| September 22, 2026 | 2.121 |
| September 21, 2026 | 1.991 |
| September 18, 2026 | 1.991 |
| September 17, 2026 | 2.034 |
| September 16, 2026 | 1.995 |
| September 15, 2026 | 1.940 |
| September 14, 2026 | 2.308 |
| September 11, 2026 | 2.373 |
| September 10, 2026 | 2.417 |
| September 09, 2026 | 2.554 |
| September 08, 2026 | 2.633 |
| September 04, 2026 | 2.676 |
| September 03, 2026 | 2.655 |
| September 02, 2026 | 2.684 |
| September 01, 2026 | 2.647 |
| Date | Value |
|---|---|
| August 31, 2026 | 2.424 |
| August 28, 2026 | 2.316 |
| August 27, 2026 | 2.467 |
| August 26, 2026 | 2.395 |
| August 25, 2026 | 2.431 |
| August 24, 2026 | 2.373 |
| August 21, 2026 | 2.366 |
| August 20, 2026 | 2.373 |
| August 19, 2026 | 2.575 |
| August 18, 2026 | 2.445 |
| August 17, 2026 | 2.489 |
| August 14, 2026 | 2.424 |
| August 13, 2026 | 2.417 |
| August 12, 2026 | 2.518 |
| August 11, 2026 | 2.489 |
| August 10, 2026 | 2.482 |
| August 07, 2026 | 2.496 |
| August 06, 2026 | 2.431 |
| August 05, 2026 | 2.417 |
| August 04, 2026 | 2.395 |
| August 03, 2026 | 2.287 |
| July 31, 2026 | 2.236 |
| July 30, 2026 | 2.366 |
| July 29, 2026 | 2.287 |
| July 28, 2026 | 2.323 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.409 |
| ACADIA Pharmaceuticals, Inc. | 2.600 |
| Alnylam Pharmaceuticals, Inc. | 22.12 |
| Savara, Inc. | 6.648 |
| Vericel Corp. | 5.538 |
Price to Book Value Related Metrics
| PS Ratio | 25.58 |
| Price | 2.56 |
| Earnings Yield | -17.85% |
| Market Cap | 557.82M |